AstraZeneca consolidates its drug development work

03/19/2013 | Reuters · USA Today

AstraZeneca plans to restructure its research and development operations to bring together drug development activities in three major facilities in the U.S., England and Sweden. A Gaithersburg, Md., facility will become the main hub for biotech research. The changes, meant to cut costs and increase productivity, will eliminate about 1,600 positions.

View Full Article in:

Reuters · USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN